KIA
OM icon

Kraematon Investment Advisors’s Outset Medical OM Stock Holding History

Kraematon Investment Advisors’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-164
Closed -$63.5K – 193
2022
Q4 		$63.5K Buy
+164
New +$46.2K 0.07% 116

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $572M AUM 67.49% 1-Year Est. Return

Kraematon Investment Advisors's OM Position: Q1 2023 in Review

Kraematon Investment Advisors sold out of Outset Medical (OM) in Q1 2023, closing a stake of 164 shares — an estimated $63.5K sold.

Kraematon Investment Advisors first reported a position in OM in Q4 2022 and held it in 1 quarter. The position peaked at $63.5K in Q4 2022. 162 funds tracked by Wall St. Rank hold OM as of Q1 2023.

  • Kraematon Investment Advisors reported no remaining Outset Medical position as of Q1 2023 after selling out during the quarter.
  • Kraematon Investment Advisors sold 164 Outset Medical shares in Q1 2023, an estimated $63.5K.
  • Kraematon Investment Advisors first reported a position in Outset Medical in Q4 2022 and held it in 1 quarter.
  • Kraematon Investment Advisors's Outset Medical position peaked at $63.5K in Q4 2022.
  • 162 funds tracked by Wall St. Rank held Outset Medical as of Q1 2023.

Based on Kraematon Investment Advisors's 13F filing for Q1 2023, filed 13 Apr 2023.